You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
17 August 2020
4basebio AG announces process for spin-off and separate stock market listing for its DNA business
20 April 2020
4basebio AG: 4basebio AG resolves on capital reduction by way of redemption of approx. 5.2 million treasury shares in accordance with the authorizing resolution of the general meeting
10 February 2020
4basebio AG: 4basebio AG decides to increase the public share buyback offer volume from 2,056,452 to 5,230,726 shares
21 January 2020
4basebio AG: 4basebio AG decides to buy back 2 million treasury shares for further use in accordance with the authorizing resolution
11 November 2019
Expedeon AG: Expedeon AG signs EUR 120 million deal with Abcam for the sale of its immunology and proteomics business
29 October 2019
Expedeon AG: Expedeon AG raises adjusted EBITDA guidance for 2019